Granules India Ltd (BOM:532482)

Q3 2025 Granules India Ltd Earnings Call Transcript

Jan 24, 2025 / 10:30 AM GMT

Release Date Price: ₹582.35 (-2.83%)

Transcript

Key Points

Positve

Granules India Ltd (BOM:532482) has implemented a comprehensive remediation plan following the US FDA inspection, with 90% of corrective actions completed.
The company has resumed operations and dispatches in October after ensuring no product contamination or patient safety concerns.
Granules India Ltd (BOM:532482) is expanding its product portfolio, with new launches from its GP I facility in the US and a focus on the ADHD, oncology, and anti-diabetic segments.
The new formulation facility at Jon Valley has commenced commercial dispatches, with phase two expected to be commissioned by Q4 FY25.
The company reported a gross margin improvement to 61.7% in Q3 FY25, up from 57% in Q3 FY24, driven by profitable sales growth of finished dosages.

Negative

The US FDA inspection resulted in six form 483 observations, leading to a temporary pause in manufacturing and distribution.
The OOA I classification may impact the review of pending submissions for approval of new products.
Granules India Ltd (BOM:532482) experienced a decline in revenue to INR7,377 million in Q3 FY25 from INR11,556 million in Q3 FY24.
The company incurred increased costs due to professional fees and failure to supply penalties related to the US FDA inspection.
There is uncertainty regarding the timeline for the US FDA's reinspection, which could delay new product approvals and launches.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GRAN.NS - Granules India Ltd
Q3 2025 Granules India Ltd Earnings Call
Jan 24, 2025 / 10:30AM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Ladies and gentlemen, good day. And welcome to Q3 and nine months FY25 earnings conference call, Gran Limited as a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call? Please signal an operator by pressing star then zero on your touch tone phone. Please note that this conference is being recorded. I now hand the conference over to MS Prachi from Orient Capital. Thank you and over to you, ma'am.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.